124 related articles for article (PubMed ID: 382504)
1. Anti-donor's B lymphocytes and anti-IgG antibodies in kidney allograft recipients: correlative study with the transplant outcome.
de Mouzon A; Soulillou JP; Blanc M; Durand D; Ohayon E; Ducos J
Transplant Proc; 1979 Jun; 11(2):1267-8. PubMed ID: 382504
[No Abstract] [Full Text] [Related]
2. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)].
Drannik GN; Driianskaia VE
Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199
[No Abstract] [Full Text] [Related]
3. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.
Reed E; Hardy M; Benvenisty A; Lattes C; Brensilver J; McCabe R; Reemstma K; King DW; Suciu-Foca N
N Engl J Med; 1987 Jun; 316(23):1450-5. PubMed ID: 3553951
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E
Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
[No Abstract] [Full Text] [Related]
5. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
7. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
8. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
[TBL] [Abstract][Full Text] [Related]
9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
10. Anti-B lymphocytotoxins in renal-allograft rejection.
Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
[TBL] [Abstract][Full Text] [Related]
11. Association of kidney transplant failure and antibodies against MICA.
Mizutani K; Terasaki P; Bignon JD; Hourmant M; Cesbron-Gautier A; Shih RN; Pei R; Lee J; Ozawa M
Hum Immunol; 2006 Sep; 67(9):683-91. PubMed ID: 17002898
[TBL] [Abstract][Full Text] [Related]
12. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
Norman PJ; Harmer AW; Koffman CG; Vaughan RW
Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
[No Abstract] [Full Text] [Related]
13. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
Nunez G; McPhaul J; Stastny P
Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
[TBL] [Abstract][Full Text] [Related]
14. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
Chia D; Horimi T; Terasaki PI; Hermes M
Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic antibodies regulate the immune response to HLA in heart allograft recipients.
Reed E; Rouah C; Hsu D; Cechova K; Rose E; Smith C; Reemstma K; King DW; Suciu-Foca N
Transplant Proc; 1989 Feb; 21(1 Pt 1):463-4. PubMed ID: 2650178
[No Abstract] [Full Text] [Related]
16. [Immunological selection of donors and recipients in renal grafts: antibodies].
Seignalet J; Mourad G; Mion C
Nephrologie; 1984; 5(1):33-9. PubMed ID: 6374486
[TBL] [Abstract][Full Text] [Related]
17. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
18. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
19. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
20. Role of anti-donor B lymphocyte antibodies in definitive allograft rejection.
Soulillou JP; de Mouzon A; Peyrat MA; Guenel J
Transplant Proc; 1979 Mar; 11(1):770-5. PubMed ID: 377710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
